Care Transition Intervention for Hospitalized Patients With Advanced Cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Advanced Cancer
- Sponsor
- Massachusetts General Hospital
- Enrollment
- 58
- Locations
- 1
- Primary Endpoint
- Feasibility using enrollment and retention on study
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
This research study is investigating an intervention called CONTINUity of care Under Management by Video visits (CONTINUUM-V). CONTINUUM-V involves a video visit with an oncology nurse practitioner within three business days of hospital discharge for patients with advanced cancer with the goal of reducing burdensome care transitions after hospitalization, including hospital readmissions.
Detailed Description
This is a single-site, single-arm pilot trial to assess the feasibility and acceptability of a CONTINUUM-V for patients with advanced cancer The research study procedures include: * A video visit with a nurse practitioner within three business days of hospital discharge * Questionnaires asking about demographic information (e.g. sex, ethnicity, income) and participant experience with cancer (e.g. symptoms and confidence in managing their health condition) * A satisfaction survey to assess the participants' impressions of the intervention and any suggestions the participants may have * Data collection from their medical record * One time interview of participant and clinician for feedback on CONTINUUM-V Participants will be in this research study for up to 45 days after hospital discharge. 54 patients and 4 clinicians took part in this research study. The Conquer Cancer Foundation and the Rising Tide Foundation for Clinical Cancer Research are supporting this research study by providing a Career Pathway Grant in Symptom Management to support the research team.
Investigators
Jennifer Temel, MD
Principal Investigator
Massachusetts General Hospital
Eligibility Criteria
Inclusion Criteria
- •Age \>= 18 years
- •Unplanned admission to the oncology service at Massachusetts General Hospital (MGH)
- •Known diagnosis of advanced breast, thoracic, genitourinary, or gastrointestinal cancers. Advanced cancer defined as not being treated with curative intent as determined by clinic notes and chemotherapy order entry.
- •Receiving ongoing oncology care at MGH
- •Verbal fluency in English
- •Must have internet/wifi/cellular data access
Exclusion Criteria
- •Admitted electively
- •Discharged to a location other than home or expired during admission
- •Discharged with hospice services
Outcomes
Primary Outcomes
Feasibility using enrollment and retention on study
Time Frame: Discharge to 3 business days
The intervention will be deemed feasible if at least 70% of eligible patients participate in the study, and if at least 70% complete the video visit within three business days of discharge.
Secondary Outcomes
- Patients' Confidence in Managing their Health Condition using the Patient Activation Measure (PAM-13)(Baseline to 15 days after discharge)
- Psychological Symptoms using the Patient Health Questionnaire-4 (PHQ-4)(Baseline to 15 days after discharge)
- Patient Satisfaction using the Patient Satisfaction Questionnaire(10 to 15 days after discharge)
- Symptom Burden using the Edmonton Symptom Assessment Scale (ESAS-r)(Baseline to 15 days after discharge)